Share on Pinterest
There are no images.

A Fit, Healthy Body - that is the Best Fashion Statement.

Want more All Good Club? Follow us:
Share on Pinterest
There are no images.

Trump agrees $2.1bn deal for 100 million doses of coronavirus vaccine with pharma giants GlaxoSmithKline and Sanofi

Share on Pinterest
There are no images.


TWO major drug companies will supply the U.S. government with 100 million doses of an experimental coronavirus vaccine.

French drug maker Sanofi and British pharmaceutical giant GlaxoSmithKline have singed a $2.1 billion deal to supply enough vaccines for 50 million people.

The deal was signed as part of 'Operation Warp Speed'

2

The deal was signed as part of ‘Operation Warp Speed’Credit: Reuters

The Sanofi-GSK deal is for 100 million doses – at two per person – and gives the U.S. government an option to purchase an additional 500 million doses.

The two companies’ inoculation is combination of a vaccine based on Sanofi’s flu shots and a complementary technology from GSK called an adjuvant, designed to improve the vaccine’s potency.

The purchase falls under the Trump administration’s so-called ‘Operation Warp Speed’, intended to bring a Covid-19 vaccine to the market by the end of 2020.

The cost works out at a cost of around $42 per person inoculated.

That is almost identical to the $40 per patient the U.S. agreed to pay Pfizer Inc and BioNTech SE when it inked a nearly $2 billion deal for 50 million courses of that potential vaccine last week.

Some 50 million people will get two doses of the vaccine

2

Some 50 million people will get two doses of the vaccine Credit: Getty Images – Getty

“The global need for a vaccine to help prevent COVID-19 is massive, and no rush a single vaccine or company will be able to meet the global demand alone,” said Thomas Triomphe, head of Sanofi’s vaccine division.

Health and Human Services  Secretary Alex Azar said the range of vaccines being increases the odds that “we will have at least one safe, effective vaccine as soon as the end of this year”.

“Today’s investment supports the Sanofi and GSK adjuvanted product all the way through clinical trials and manufacturing, with the potential to bring hundreds of millions of safe and effective doses to the American people.”

The agreement marks the second contract for the Franco-British pair’s vaccine candidate after they agreed earlier this week to supply 60 million doses to the British government.

Sanofi and GSK plan to start clinical trials for the vaccine in September.

GSK said statement that more than half of the total funding will go into further development of the vaccine, including clinical trials

The remainder used for a manufacturing ramp-up and delivery of doses.

 





Source link



Leave a Reply

Your email address will not be published. Required fields are marked *

FREE DIET

 

MEAL PLAN

Low-Carb Recipes You'll Fall For!

Enter your email

and download it today for free!

World is waiting for you!

FREE

MEAL PLAN

FOR YOU!

THANK YOU!